Building an Evidence Base for Deprescribing in the Setting of Polypharmacy
JAMA Network Open · 30.07.2024 · 7 (7) · e2423529
DOI: 10.1001/jamanetworkopen.2024.23529 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Network Open, online erschienen am 30.07.2024. Verfasst von Michelle C Odden. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Stanford University, Stanford, California. Hauptthemen laut MEDLINE: Polypharmacy, Deprescriptions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: NIA NIH HHS.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kenya Ie, MD, MPH, PhD; Masanori Hirose, MD, PhD; Tsubasa Sakai, MD; Iori Motohashi, MD, MPH; Mari Aihara, MD; Takuya Otsuki, MD, PhD; Ayako Tsuboya, PharmD, PhD; Hiroshi Matsumoto, PharmD; Hikari Hashi, PharmD; Eisuke Inoue, PhD; Masaki Takahashi, MSc; Eiko Komiya, PharmD; Yuka Itoh, PharmD; Reiko Machino, PharmD; Tomoya Tsuchida, MD, PhD; Steven M. Albert, PhD; Yoshiyuki Ohira, MD, PhD; Chiaki Okuse, MD, PhD
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Population Health, Stanford University, Stanford, California.
- Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California.
Förderung
- NIA NIH HHS
Zitieren
APA
Odden, M. C. (2024). Building an Evidence Base for Deprescribing in the Setting of Polypharmacy. JAMA Network Open, 7(7), e2423529. https://doi.org/10.1001/jamanetworkopen.2024.23529
Vancouver
Odden MC. Building an Evidence Base for Deprescribing in the Setting of Polypharmacy. JAMA Network Open. 2024;7(7):e2423529. doi:10.1001/jamanetworkopen.2024.23529
BibTeX
@article{Odden2024,
author = {Odden, Michelle C},
title = {Building an Evidence Base for Deprescribing in the Setting of Polypharmacy},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {7},
pages = {e2423529},
doi = {10.1001/jamanetworkopen.2024.23529}
}
EUVIMED